The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 640 participants.

Also called NCT03627130

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 640 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03627130
Other papers using this trial's data
  • Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial European heart journal, 2024-05-13 DOI, PubMed 38513060, PMC11089333 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03627130. Randomized; quadruple masking; primary purpose treatment. Start 2018-11-29 (actual); primary completion 2022-05-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
Acronym
NITRATE-CIN
Condition
Contrast-induced Nephropathy
Condition
Acute Coronary Syndrome
Intervention (Drug)
Potassium Nitrate
Intervention (Drug)
Potassium Chloride
Lead sponsor
Barts & The London NHS Trust (class: other)

Record details

Record id
cardio:ct-nct03627130
Content hash
e9740dd4e178965dbc50ee9064124de01c676f6adae06a7bb104390945ee7632